top of page

Editorial Recommendations of the Month

Key articles from high impact journals in last month

Febuary 2023

Thioguanine is effective as maintenance therapy for inflammatory bowel disease: a prospective multicentre registry study

GATA6-AS1 regulates intestinal epithelial mitochondrial functions, and its reduced expression is linked to intestinal inflammation and less favorable disease course in ulcerative colitis (UC)

A compendium of mucosal molecular characteristics provides novel perspectives on the treatment of ulcerative colitis

Min-Jing ChangJia-Wei HaoJun QiaoMiao-Ran ChenQian WangQi WangSheng-Xiao ZhangQi YuPei-Feng He

Published on 23 Jan 2023, Journal of Crohn's & colitis

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial

Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results from a Randomized, Phase 2b Study

Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease

Venous thromboembolism risk stratification for patients undergoing surgery for IBD using a novel six factor scoring system using NSQIP-IBD registry

Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn’s disease


bottom of page